for the transfer of manufacturing technology for Covid-19 and cancer vaccines and next-generation cell-based immunotherapies.
During the official launch of the partnership on Thursday evening, 23 September, the founder of NantWorks, South African-born Dr Patrick Soon-Shiong, who left the country as a young physician nearly three decades ago, said the initiative was a dream come true. “This technology transfer, including manufacturing biologics, will reinforce vaccine equity sorely needed globally,” said Ramaphosa, acknowledging the opportunity to address the public health challenges experienced in South Africa and the continent and leapfrog to cutting edge technology.”
Under the agreement, the Centre for Epidemic Response and Innovation will be launched in collaboration with the SAMRC and the universities of Stellenbosch and KwaZulu-Natal and will primarily focus on the genomic surveillance of, and response to, viral mutations occurring in Africa.
Forex is really a great opportunity which favoured me and I really can't thank Mr Christ and his team for such a wonderful mentorship and profitability. He is really an amazing trader. You wish to trade forex connect with him ChristUSA_